Effect of HA-1A Monoclonal IGM Antibody on Endotoxin-Induced Proliferation of Cultured Rat Middle Ear Epithelium

Abstract

The effect of human monoclonal antibody HA-1A (Centoxin) on the effect of endotoxin on cultured rat middle ear epithelium was investigated. The addition of endotoxin to the standard culture medium revealed a concentration-related proliferative effect on cultured rat middle ear epithelium, leading to cobblestone cells, cell tracks, and stratification of epithelium, whereas rat middle ear epithelium cultured in standard medium grew as a monolayer composed of flat polygonal cells. Addition of HA-1A to standard medium supplemented with endotoxin gave rise to a statistically significant suppression of the proliferative effects of endotoxin on these cells. The morphology of rat middle ear epithelium cultured in the presence of HA-1A and endotoxin showed that these cells still had a tendency to form cobblestone-like cells and cell tracks, but to a substantially lower degree. The present results support the hypothesis that HA-1A suppresses the proliferative and morphological effects of endotoxin on rat middle ear epithelium and may play an important role in the pathogenesis of otitis media.

Keywords

anti-endotoxin endotoxin otitis media rat middle ear epithelium tissue culture

Get full access to this article

View all access options for this article.

References

Van Blitterswijk

Lim

DeMaria

Hesseling

Grote

. The effect of endotoxin on cultured middle ear epithelium and meatal epidermis. In: Sadé

, ed. The eustachian tube. Amsterdam, the Netherlands: Kugler, 1991: 143–9.

Nakamura

DeMaria

van Blitterswijk

Lim

. Effect of endotoxin on cultured chinchilla middle ear epithelium. Ann Otol Rhinol Laryngol 1992;101: 607–11.

Lim

DeMaria

. Panel discussion: Pathogenesis of otitis media. Bacteriology and immunology. Laryngoscope 1982;92: 278–86.

Lino

Kaneko

Takasaka

. Endotoxin in middle ear effusions tested with Limulus assay. Acta Otolaryngol (Stockh) 1985;100: 42–50.

DeMaria

Prior

Briggs

Lim

Birck

. Endotoxin in middle ear effusions from patients with chronic otitis media with effusion. J Clin Microbiol 1984;20: 15–7.

Jinnin

Dake

Kusumoto

Tabata

. Quantitative determination of bacterial endotoxin in middle ear effusions by chromogenic substrate methods. Auris Nasus Larynx 1985;12: 897–9.

DeMaria

Lim

. Inflammatory changes in the middle ear and eustachian tube induced by viable or nonviable Hemophilus influenzae or its endotoxin. Ann Otol Rhinol Laryngol 1985;94 (supp1 120): 14–6.

Nonomura

Nakano

Satoh

Fuyioka

Niijima

Fujita

. Otitis media with effusion following inoculation of Hemophilus influenzae type B endotoxin. Arch Otorhinolaryngol 1986;243: 31–5.

Mackensen

Galanos

Engelhardt

. Treatment of cancer patients with endotoxin induces release of endogenous cytokines. Pathobiology 1991;59: 264–7.

10.

Spooner

Markowitz

Saravolatz

. The role of tumor necrosis factor in sepsis. Clin Immunol Immunopathol 1992;62: 11–7.

11.

Moriyama

Huang

Abramson

. Cell cooperation on bone resorption in chronic otitis media. Arch Otorhinolaryngol 1984;241: 89–93.

12.

Siegel

Evans

Pollack

. Antibiotics enhance binding by human lipid A-reactive monoclonal antibody HA-1A to smooth gram-negative bacteria. Infect Immun 1993;61: 512–9.

13.

Warren

Danner

Munford

. Antiendotoxin monoclonal antibodies. N Engl J Med 1992;326: 1153–6.

14.

Ziegler

Smith

. Anti-endotoxin monoclonal antibodies. N Engl J Med 1992;326: 1165.

15.

Bogard

Jr Dunn

Abemethy

Kilgarriff

Kung

. Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity. Infect Immun 1987;55: 899–908.

16.

Bone

. Monoclonal antibodies to endotoxin. New allies against sepsis? JAMA 1991;266: 1125–6.

17.

Young

Gascon

Alam

Bermudez

LEM

. Monoclonal antibodies for treatment of gram-negative infections. Rev Infect Dis 1989;11: 1564–71.

18.

Bogard

Siegel

Leone

. Human monoclonal antibody HA-1A binds to endotoxin via an epitope in the lipid A domain of lipopolysaccharide. J Immunol 1993;150: 4438–49.

19.

Ziegler

Fisher

Sprung

. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. N Engl J Med 1991;324: 429–36.

20.

EditorialEndotoxin bound and gagged. Lancet 1991;337: 588–9.

21.

Wortel

Von der Mohlen

MAM

Van Deventer

SJH

. Effectiveness of a monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels. J Infect Dis 1992;166: 1367–74.

22.

Greenman

Schein

RMH

Martin

. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. JAMA 1991;266: 1097–102.

23.

Van Blitterswijk

Ponec

Van Muijen

GNP

Wijsman

Koerten

Grote

. Culture and characterization of rat middle-ear epithelium. Acta Otolaryngol (Stockh) 1986;101: 453–66.

24.

Parent

Gazzano-Santoro

Wood

. Reactivity of monoclonal antibody E5 with endotoxin. Circ Shock 1992;38: 63–73.

25.

Wenzel

. Anti-endotoxin monoclonal antibodies — a second look. N Engl J Med 1992;326: 1151–3.

26.

Chalfin

Holbein

MEB

Fein

Carlon

. Cost-effectiveness of monoclonal antibodies to gram-negative endotoxin in the treatment of gram-negative sepsis in ICU patients. JAMA 1993;269: 249–54.

27.

Schulman

Glick

Rubin

Eisenberg

. Cost-effectiveness of HA-1A monoclonal antibody for gram-negative sepsis. JAMA 1991;266: 3466–71.

28.

Shepherd

. Criteria for use of antiendotoxin monoclonal antibodies (HA-1 A and E5) in adult and pediatric patients. Clin Pharm 1992;11: 257–60.